Mariner
HURA

Mariner’s TuHURA Biosciences HURA Stock Holding History

Mariner’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46K Buy
+25,697
New +$31.5K ﹤0.01% 3433
2022
Q4 		– Sell
-10
Closed -$2K – 2855
2022
Q3 		$2K Buy
+10
New +$3.2K ﹤0.01% 2439

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Mariner's HURA Position: Q1 2026 in Review

Mariner opened a new position in TuHURA Biosciences (HURA) in Q1 2026: 25,697 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #3433 among its holdings. This is a return to the name: Mariner previously reported a position in HURA as recently as Q3 2022.

Mariner first reported a position in HURA in Q3 2022 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Mariner held 25,697 shares of TuHURA Biosciences worth $46K as of Q1 2026.
  • TuHURA Biosciences was a new Mariner position in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3433 holding.
  • Mariner first reported a position in TuHURA Biosciences in Q3 2022 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.